| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 09/08/2011 | US20110217244 Compositions and methods for enhancing immune response |
| 09/07/2011 | EP2363126A1 Composition comprising as active ingredient L-carnitine in combination with hydroxykynurenine-O-beta-DL-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation |
| 09/07/2011 | EP2362730A1 Adamantyl benzamide compounds |
| 09/07/2011 | CN102177178A Anti-IL-12/IL-23 antibodies |
| 09/07/2011 | CN102174024A 2,4-pyrimidinediamine compounds and their uses |
| 09/07/2011 | CN102172407A Rnai inhibition of serum amyloid a for treatment of glaucoma |
| 09/07/2011 | CN102172382A Traditional Chinese medicine for treating diabetic retinopathy |
| 09/07/2011 | CN102172376A Traditional Chinese medicine for treating diabetic oculopathy |
| 09/07/2011 | CN102172357A Core 2 glcnac-t inhibitors |
| 09/07/2011 | CN101745176B Brain refreshing and eyesight improving health care bag |
| 09/07/2011 | CN101597294B 3-aminoalkaneacylamino-rutaecarpine and 3-aminoalkaneacylamino-7,8-dehydrorutaecarpine derivative |
| 09/07/2011 | CN101573118B Aqueous liquid preparation comprising gatifloxacin |
| 09/07/2011 | CN101434657B Preparation and use of recombinant mtVEGF121/MAP30KDEL fusion noxioussubstance |
| 09/06/2011 | US8012996 Methods and composition for inhibition of angiogenesis |
| 09/06/2011 | US8012995 Pharmaceutically active sulfonamide derivatives |
| 09/06/2011 | US8012965 e.g. 1-(2-chloro-7-methylthieno[3,2-d]pyrimidin-4-yl)-N3-(5,7-ethano-5,7,8-trihydro-6-methyl-1,6-naphthyridin-3-yl)-1H-1,2,4-triazole-3,5-diamine; angiogenesis inhibitor, antiproliferative agent |
| 09/06/2011 | CA2493785C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 09/06/2011 | CA2465746C Hydrazono-malonitriles |
| 09/01/2011 | WO2011106702A2 Sustained delivery of therapeutic agents to an eye compartment |
| 09/01/2011 | WO2011106697A1 Therapeutic compositions for the treatment of dry eye disease |
| 09/01/2011 | WO2011106599A1 Method of accelerating corneal wound healing |
| 09/01/2011 | WO2011106414A1 Inhibitors of beta-secretase |
| 09/01/2011 | WO2011105099A1 Compound containing a novel 4-alkoxypyridine formation and medicine containing same |
| 09/01/2011 | WO2011104981A1 Eye drops for treating eye infection containing levofloxacin, salt thereof or solvate of same, method for treating eye infection, levofloxacin, salt thereof or solvate of same, and utilization thereof |
| 09/01/2011 | WO2011104568A1 Treatment of oxidative stress disorders |
| 09/01/2011 | WO2011103667A1 Agonistic antibodies to trkb receptors and uses thereof |
| 09/01/2011 | US20110213039 Infant formulas containing docosahexaenoic acid and lutein |
| 09/01/2011 | US20110213029 3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor Ligands |
| 09/01/2011 | US20110213008 Pharmaceutical containing hif-1 alpha and hif-2 alpha expression inhibitor |
| 09/01/2011 | US20110212993 Medicament for treating glaucoma comprising as an active ingredient cyclodextrin-clathrate compound of cilostazol |
| 09/01/2011 | US20110212992 Novel p2x7r antagonists and their use |
| 09/01/2011 | US20110212989 Therapeutic methods and compositions involving isoflavones |
| 09/01/2011 | US20110212962 P38 map kinase inhibitors |
| 09/01/2011 | US20110212959 Cyanoisoquinoline Compounds and Methods of Use Thereof |
| 09/01/2011 | US20110212951 Human protein tyrosine phosphatase inhibitors and methods of use |
| 09/01/2011 | US20110212932 Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammation |
| 09/01/2011 | US20110212925 Novel compounds as receptor modulators with therapeutic utility |
| 09/01/2011 | US20110212919 Protein cross-linking inhibitor |
| 09/01/2011 | US20110212899 Corneal Neuritogenesis Promoter Containing Pacap and Its Derivative |
| 09/01/2011 | US20110212885 Ophthalmic and contact lens solutions containing peptides as preservative |
| 09/01/2011 | US20110212883 Radical scavenger and active oxygen eliminating agent |
| 09/01/2011 | US20110212200 Agent for treating eye diseases |
| 09/01/2011 | US20110212199 Agent for treating eye diseases |
| 09/01/2011 | US20110212188 Preventing and/or treating cardiovascular disease and/or associated heart failure |
| 09/01/2011 | US20110212167 Lipid based pharmaceutical preparations for oral and topical application; their compositions, methods, and uses thereof |
| 09/01/2011 | US20110212154 Biodegradable Implantable Drug Delivery Device |
| 09/01/2011 | US20110212142 Curcuminoids and its metabolites for the application in ocular diseases |
| 09/01/2011 | US20110212097 Methods and Compositions to Treat and Detect Misfolded-SOD1 Mediated Diseases |
| 09/01/2011 | US20110212084 Binding members for ige molecules |
| 09/01/2011 | US20110212051 Variants of vascular endothelial growth factor (vegf) receptor and use thereof |
| 09/01/2011 | US20110212047 Polymer Therapy for the Treatment of Chronic Microvascular Diseases |
| 09/01/2011 | CA2791278A1 Sustained delivery of therapeutic agents to an eye compartment |
| 09/01/2011 | CA2791190A1 Ophthalmic solution for treating ocular infection comprising levofloxacin or salt thereof or solvate of the same, method for treating ocular infection, levofloxacin or salt thereof or solvate of the same, and use thereof |
| 09/01/2011 | CA2788333A1 Method of accelerating corneal wound healing |
| 08/31/2011 | EP2361910A1 Compound having tafia inhibitory activity |
| 08/31/2011 | EP2361635A2 Anti IgE vaccines |
| 08/31/2011 | EP2361306A1 Compositions and methods for selective inhibition of pro-angiogenic vegf isoforms |
| 08/31/2011 | EP2361253A1 Compounds |
| 08/31/2011 | EP2117553B1 Compositions for treating, reducing, ameliorating, or preventing infections of the ear or upper respiratory track |
| 08/31/2011 | EP1095140B1 Neurotrophic factors |
| 08/31/2011 | CN102170872A Method of modulating membrane potential of a cell |
| 08/31/2011 | CN102170865A Eye drop with difluprednate for macular edema treatment |
| 08/31/2011 | CN102166376A Ophthalmic medicine-carried amnion and preparation method thereof |
| 08/31/2011 | CN102166358A Use of inhibitors of jun N-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases |
| 08/31/2011 | CN102166357A Medicinal composition containing bicyclic aza-alkane derivative |
| 08/31/2011 | CN102166328A Traditional Chinese medicine preparation for curing visual fatigue, teen-age amblyopia, pseudomyopia and myopia |
| 08/31/2011 | CN102166246A Oil-in-water type atractylis oil nano emulsion oral liquid |
| 08/31/2011 | CN102166215A Pharmaceutical composition containing piperazine derivatives |
| 08/31/2011 | CN102166205A New medical application of paeonol and derivatives thereof |
| 08/31/2011 | CN102166203A Eye pad for alleviating eye fatigue and preparation method thereof |
| 08/31/2011 | CN101884693B Traditional Chinese medicine for treating diabetic eye diseases |
| 08/31/2011 | CN101703687B Chinese medicinal decoction for treating glaucoma |
| 08/31/2011 | CN101695504B Preparation method of nanometer pearl powder |
| 08/30/2011 | US8008345 Preventing, alleviating symptoms of a skin condition with a complexes, such as lauryliminodipropionic acid tocopheryl phosphate; penetrating and absorption into skin; inflammation, erythema, wound, burn, dermatitis, gingivitis, sunburn, heat burn, psoriasis; cosmetics |
| 08/30/2011 | US8008338 Ketorolac tromethamine compositions for treating or preventing ocular pain |
| 08/30/2011 | US8007830 Oral granules of montelukast sodium; e.g. spray-dried mannitol coated with said drug; may be ingested directly or mixed with food or other comestibles for patients who have difficulty swallowing |
| 08/30/2011 | US8007799 Vascular endothelial cell growth factor antagonists and uses thereof |
| 08/30/2011 | CA2440473C Metalloproteinase inhibitors |
| 08/30/2011 | CA2414950C Method and kit for moisturizing the surface of the eye |
| 08/30/2011 | CA2406392C Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis |
| 08/25/2011 | WO2011103423A1 Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors |
| 08/25/2011 | WO2011102404A1 Imidazole derivative |
| 08/25/2011 | WO2011101478A1 USE OF TRANSFORMING GROWTH FACTOR - BETA 1 (TGF-β1) INHIBITOR PEPTIDES FOR THE TREATMENT OF CORNEAL FIBROSIS AND/OR HAZE |
| 08/25/2011 | US20110207809 Method of accelerating corneal wound healing |
| 08/25/2011 | US20110207757 Tricyclic Compounds Having Cytostatic and/or Cytoxic Activity and Methods of Use Thereof |
| 08/25/2011 | US20110207754 Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors |
| 08/25/2011 | US20110207732 Azaindole derivatives |
| 08/25/2011 | US20110207730 Ion channel modulating compounds and uses thereof |
| 08/25/2011 | US20110207718 Compositions and methods for treating psychiatric disorders |
| 08/25/2011 | US20110207714 Serotonin receptor modulators |
| 08/25/2011 | US20110207695 Agent for applying to mucosa and method for the production thereof |
| 08/25/2011 | US20110207689 The treatment of hearing loss |
| 08/25/2011 | US20110207668 Binding proteins inhibiting the vegf-a receptor interaction |
| 08/25/2011 | US20110206773 Sustained delivery of drugs from biodegradable polymeric microparticles |
| 08/25/2011 | US20110206760 Angiopoietin derived peptides |
| 08/25/2011 | US20110206745 Octreotide implant having a release agent |
| 08/25/2011 | US20110206652 Methods for treating atherosclerosis |
| 08/25/2011 | US20110206620 Therapeutic Compositions for the Treatment of Dry Eye Disease |
| 08/25/2011 | US20110206612 Novel screens to identify agents that modulate retinal blood vessel function and pericyte function and diagnostic and therapeutic application therefor |
| 08/25/2011 | US20110206610 Compositions and methods for enhancing drug delivery across and into epithelial tissues |